Research in Peripheral Neuropathic Pain with IncobotulinumtoxinA: Pre-clinical and PaiNT Phase 2 Study Results (Merz Therapeutics Company Supported Lunch Symposia)

This symposium highlights recent research in peripheral neuropathic pain and insights from the Phase 2 PaiNT study. Expert speakers will discuss disease burden, current management challenges, patient-relevant outcomes, safety and tolerability, and methodological considerations for future clinical research in postherpetic neuralgia and post-surgical/post-traumatic neuropathic pain.